Register Of Innovative Drugs
|
|
- Kory West
- 5 years ago
- Views:
Transcription
1 Products for Human Use - Active Period Register Of s File" abiraterone acetate Zytiga Janssen Inc. N/A N/A aclidinium bromide Tudorza Genuair AstraZeneca Canada Inc. Duaklir Genuair N/A afatinib dimaleate Giotrif Boehringer Ingelheim (Canada) Ltd. N/A N/A aflibercept Eylea Bayer Inc. N/A N/A albiglutide Eperzan GlaxoSmithKline Inc. N/A N/A alectinib hydrochloride Alecensaro Hoffmann-La Roche Limited N/A N/A alirocumab Praluent Sanofi-aventis Canada Inc. N/A N/A alogliptin benzoate Nesina Takeda Canada Inc. Kazano Oseni N/A anthrax immune globulin (human) Anthrasil Emergent BioSolutions Canada Inc. N/A Yes antihemophilic factor (recombinant BDD), Fc fusion protein Eloctate Bioverativ Canada Inc. N/A Yes antihemophilic factor (recombinant), pegylated Adynovate Baxalta Canada Corporation N/A Yes antihemophilic factor (recombinant, B- domain deleted) (also known as simoctocog alfa) Nuwiq Octapharma Pharmazeutika Produktionsges.m.b.H N/A Yes antihemophilic factor VIII (recombinant), singlechain (also known as lonoctocog alfa) Afstyla CSL Behring Canada Inc. N/A Yes anthrax antigen filtrate Biothrax Emergent Biodefense Operations Lansing LLC N/A N/A Page 1 of
2 Products for Human Use - Active Period Register Of s File" apalutamide Erleada Janssen Inc. N/A N/A apixaban Eliquis Bristol-Myers Squibb Canada N/A Yes apremilast Otezla Celgene Inc. N/A N/A asenapine maleate Saphris Merck Canada Inc. N/A Yes asfotase alfa Strensiq Alexion Pharma International Sàrl N/A Yes asunaprevir Sunvepra Bristol-Myers Squibb Canada N/A N/A atezolizumab Tecentriq Hoffmann-La Roche Limited N/A N/A avelumab Bavencio EMD Serono, a Division of EMD Inc., Canada N/A N/A axitinib Inlyta Pfizer Canada Inc. N/A Yes azelastine hydrochloride Dymista Meda Pharmaceuticals Ltd. N/A Yes azilsartan medoxomil potassium Edarbi Valeant Canada LP Edarbyclor N/A baricitinib Olumiant Eli Lilly Canada Inc. N/A N/A bazedoxifene acetate Duavive Pfizer Canada Inc. N/A N/A belimumab Benlysta GlaxoSmithKline Inc. N/A N/A bendamustine hydrochloride Treanda Teva Canada Limited N/A Yes benralizumab Fasenra AstraZeneca Canada Inc. N/A Yes bepotastine besilate Bepreve Bausch and Lomb Incorporated N/A Yes Page 2 of
3 Products for Human Use - Active Period Register Of s File" bictegravir Biktarvy Gilead Sciences Canada, Inc. N/A N/A bilastine Blexten Aralez Pharmaceutials Canada Inc. N/A Yes blinatumomab Blincyto Amgen Canada Incorporated N/A Yes boceprevir Victrelis Merck Canada Inc. Victrelis Triple N/A bosutinib Bosulif Pfizer Canada Inc. N/A N/A botulism antitoxin heptavalent C/ D/F/ G (equine) Bat Emergent BioSolutions Inc. N/A Yes brentuximab vedotin Adcetris Seattle Genetics Inc. N/A N/A brexpiprazole Rexulti Otsuka Pharmaceutical Co. Ltd. N/A N/A brigatinib Alunbrig Takeda Canada Incorporated N/A N/A brivaracetam Brivlera UCB Canada Incorporated N/A Yes brodalumab Siliq Valeant Canada LP/Valeant Canada S.E.C. N/A N/A bromfenac sodium sesquihydrate Prolensa Bausch & Lomb Incorporated N/A N/A cabazitaxel Jevtana Sanofi-aventis Canada Inc. N/A Yes cabozantinib (supplied as cabozantinib (S)-malate) Cabometyx Ipsen Biopharmaceuticals Canada Inc. N/A N/A calcifediol Rayaldee Vifor Fresenius Medical Care Renal Pharma Ltd N/A N/A canagliflozin Invokana Janssen Inc. Invokamet Invokamet XR N/A Page 3 of
4 Products for Human Use - Active Period Register Of s File" carfilzomib Kyprolis Amgen Canada Inc. N/A N/A carglumic acid Carbaglu Orphan Europe Sarl N/A Yes catridecacog Tretten Novo Nordisk Canada Inc. N/A Yes catumaxomab Removab Fresenius Biotech GmbH N/A N/A ceftolozane Zerbaxa Merck Canada Inc. N/A N/A ceritinib Zykadia Novartis Pharmaceuticals Canada Inc. N/A N/A cerliponase alfa Brineura Biomarin International Limited N/A Yes clevidipine Cleviprex Chiesi Farmaceutici S.p.A. N/A N/A coagulation factor IX (recombinant), albumin fusion protein Idelvion CSL Behring Canada Inc. N/A Yes coagulation factor IX (recombinant), pegylated (nonacog beta pegol) Rebinyn Novo Nordisk Canada Inc. N/A Yes coagulation factor IX, Fc fusion protein Alprolix Bioverativ Canada Inc. N/A Yes cobimetinib Cotellic Hoffmann-La Roche Limited N/A N/A colesevelam hydrochloride Lodalis Valeant Canada LP / Valeant Canada S.E.C. N/A N/A collagenase clostridium histolyticum Xiaflex Endo Ventures Ltd. N/A N/A crisaborole Eucrisa Pfizer Canada Inc. N/A Yes Page 4 of
5 Products for Human Use - Active Period Register Of s File" crizotinib Xalkori Pfizer Canada Inc. N/A Yes cysteamine bitartrate Procysbi Horizon Pharma Ireland Ltd. N/A Yes dabrafenib mesylate Tafinlar Novartis Pharmaceuticals Canada Inc. N/A N/A daclatasvir Daklinza Bristol-Myers Squibb Canada N/A N/A daclizumab beta Zinbryta Biogen Canada Inc. N/A N/A dalbavancin (supplied as dalbavancin hydrochloride) Xydalba Cipher Pharmaceuticals Inc. N/A N/A damoctocog alfa pegol Jivi Bayer Inc. N/A Yes dapagliflozin propanediol Forxiga AstraZeneca Canada Inc. Xigduo Qtern N/A daratumumab Darzalex Janssen Inc. N/A N/A deferiprone Ferriprox ApoPharma Inc. N/A Yes defibrotide sodium Defitelio Jazz Pharmaceuticals Ireland Limited N/A Yes dienogest Visanne Bayer Inc. Natazia Yes difluprednate Durezol Novartis Pharmaceuticals Canada Inc. N/A Yes dimethyl fumarate Tecfidera Biogen Idec Canada Inc. N/A N/A dinutuximab Unituxin United Therapeutics Corporation N/A Yes dolutegravir sodium Tivicay ViiV Healthcare ULC Triumeq Juluca Yes doravirine Pifeltro Merck Canada Inc. Delstrigo N/A Page 5 of
6 Products for Human Use - Active Period Register Of s File" dulaglutide Trulicity Eli Lilly Canada Inc. N/A N/A dupilumab Dupixent Sanofi-Aventis Canada Inc. N/A N/A durvalumab Imfinzi AstraZeneca Canada Inc. N/A N/A edaravone Radicava Mitsubishi Tanabe Pharma Corporation N/A N/A edoxaban Lixiana Servier Canada Inc. N/A N/A efinaconazole Jublia Valeant Canada LP / Valeant Canada S.E.C. N/A N/A elagolix Orilissa AbbVie Corporation N/A N/A eliglustat tartrate Cerdelga Genzyme Canada, A division of Sanofiaventis Canada Inc. N/A N/A elosulfase alfa Vimizim Biomarin International Limited N/A Yes elotuzumab Empliciti Bristol-Myers Squibb Canada N/A N/A eltrombopag olamine Revolade Novartis Pharmaceuticals Canada Inc. N/A Yes eluxadoline Viberzi Allergan Pharma Co. N/A N/A elvitegravir, cobicistat Stribild Gilead Sciences Canada Inc. Tybost Vitekta Prezcobix Evotaz Genvoya Symtuza N/A emicizumab Hemlibra Hoffmann-La Roche Limited N/A Yes empagliflozin Jardiance Boehringer Ingelheim (Canada) Ltd. Synjardy Glyxambi N/A Page 6 of
7 Products for Human Use - Active Period Register Of s File" enzalutamide Xtandi Astellas Pharma Canada Inc. N/A N/A erenumab Aimovig Novartis Pharmaceuticals Canada Inc. N/A N/A eribulin mesylate Halaven Eisai Limited N/A N/A ertugliflozin Steglatro Merck Canada Inc. Steglujan Segluromet N/A eslicarbazepine acetate Aptiom Sunovion Pharmaceuticals Canada Inc. N/A Yes evolocumab Repatha Amgen Canada Inc. N/A Yes exenatide Byetta AstraZeneca Canada Inc. Bydureon N/A ezogabine Potiga GlaxoSmithKline Inc. N/A N/A fampridine Fampyra Biogen Idec Canada Inc. N/A N/A ferumoxytol Feraheme AMAG Pharmaceuticals Inc. N/A N/A fesoterodine fumarate Toviaz Pfizer Canada Inc. N/A Yes fidaxomicin Dificid Merck Canada Inc. N/A N/A finafloxacin Xtoro Alcon Canada Inc. N/A Yes fingolimod hydrochloride Gilenya Novartis Pharmaceuticals Canada Inc. N/A N/A flibanserin Addyi Sprout Pharmaceuticals Inc. N/A N/A Page 7 of
8 Register Of s Products for Human Use - Active Period florbetaben (18F) Neuraceq Isologic Innovative Radiopharmaceuticals Ltd. File" N/A N/A follitropin delta Rekovelle Ferring Inc. N/A N/A gadoterate meglumine Dotarem Guerbet N/A Yes galsulfase Naglazyme BioMarin Pharmaceutical Inc. N/A Yes glecaprevir, pibrentasvir Maviret AbbVie Corporation N/A N/A glycerol phenylbutyrate Ravicti Horizon Pharma Ireland Ltd. N/A Yes grazoprevir, elbasvir Zepatier Merck Canada Inc. N/A N/A guanfacine hydrochloride Intuniv XR Shire Pharma Canada ULC. N/A Yes guselkumab Tremfya Janssen Inc. N/A N/A haemagglutinin strain A (H5N1) Arepanrix H5N1 ID Biomedical Corporation of Quebec N/A Yes hemin Panhematin Recordati Rare Diseases Canada Inc. N/A N/A ibrutinib Imbruvica Janssen Inc. N/A N/A icatibant acetate Firazyr Shire Orphan Therapies Inc. N/A N/A idarucizumab Praxbind Boehringer Ingelheim (Canada) Ltd N/A N/A idelalisib Zydelig Gilead Sciences Canada Inc. N/A N/A indacaterol maleate Onbrez Breezhaler Novartis Pharmaceuticals Canada Inc. Ultibro Breezhaler N/A Page 8 of
9 Products for Human Use - Active Period Register Of s File" ingenol mebutate Picato Leo Pharma Inc. N/A N/A inotersen sodium Tegsedi Akcea Therapeutics Inc. N/A N/A inotuzumab ozogamicin Besponsa Pfizer Canada Inc. N/A N/A insulin degludec Tresiba Novo Nordisk Canada Inc. Xultophy Yes ioflupane ( 123 I) Datscan GE Healthcare Canada Inc. N/A N/A ipilimumab Yervoy Bristol-Myers Squibb Canada N/A Yes iron isomaltoside Monoferric Pharmacosmos A/S N/A N/A isavuconazole (supplied as isavuconazonium sulfate) Cresemba Avir Pharma Inc. N/A N/A ivabradine hydrochloride Lancora Servier Canada Inc. N/A Yes ivacaftor Kalydeco Vertex Pharmaceuticals (Canada) Inc. Orkambi Symdeko Yes ivermectin Rosiver Galderma Canada Inc. N/A N/A ixazomib (supplied as ixazomib citrate) Ninlaro Takeda Canada Inc. N/A N/A ixekizumab Taltz Eli Lilly Canada Inc. N/A N/A lanadelumab Takhzyro Shire Pharma Canada ULC N/A Yes ledipasvir Harvoni Gilead Sciences Canada Inc. N/A Yes lenvatinib mesylate Lenvima Eisai Limited N/A N/A letermovir Prevymis Merck Canada Inc. N/A N/A Page 9 of
10 Products for Human Use - Active Period Register Of s File" levomilnacipran hydrochloride Fetzima Allergan Inc. N/A N/A lifitegrast Xiidra Shire Pharma Canada ULC N/A N/A linaclotide Constella Forest Laboratories Canada Inc. N/A N/A linagliptin Trajenta Boehringer Ingelheim (Canada) Ltd. Jentadueto Glyxambi N/A lixisenatide Adlyxine Sanofi-aventis Canada Inc. Soliqua N/A lomitapide mesylate Juxtapid Aegerion Pharmaceuticals Canada Ltd. N/A N/A lubiprostone Amitiza Sucampo Pharma Americas LLC N/A N/A lumacaftor Orkambi Vertex Pharmaceuticals (Canada) Incorporated lurasidone hydrochloride Latuda Sunovion Pharmaceuticals Canada Inc. N/A Yes N/A Yes macitentan Opsumit Actelion Pharmaceuticals Ltd. N/A N/A mepolizumab Nucala GlaxoSmithKline Inc. N/A Yes midostaurin Rydapt Novartis Pharmaceuticals Canada Inc. N/A Yes mifepristone Mifegymiso Linepharma International Limited N/A Yes migalastat hydrochloride Galafold Amicus Therapeutics UK LTD N/A N/A mirabegron Myrbetriq Astellas Pharma Canada Inc. N/A N/A modified vaccinia virus (ankarabavarian nordic) Imvamune Bavarian Nordic A/S N/A N/A naloxegol oxalate Movantik Knight Therapeutics Inc. N/A N/A Page 10 of
11 Products for Human Use - Active Period Register Of s File" nebivolol hydrochloride Bystolic Allergan Inc. N/A N/A necitumumab Portrazza Eli Lilly Canada Inc. N/A N/A neisseria meningitidis serogroup A polysaccharide, neisseria meningitidis serogroup C polysaccharide, neisseria meningitidis serogroup W- 135 polysaccharide, neisseria meningitidis serogroup Y polysaccharide, conjugated to tetanus toxoid carrier protein Nimenrix Pfizer Canada Inc. N/A Yes Neisseria meningitidis serogroup B recombinant lipoprotein 2086 (rlp2086) subfamily A and Neisseria meningitidis serogroup B recombinant lipoprotein 2086 (rlp2086) subfamily B Trumenba Pfizer Canada Inc. N/A Yes netupitant Akynzeo Purdue Pharma N/A N/A nintedanib (supplied as nintedanib esilate) Ofev Boehringer Ingelheim (Canada) Ltd N/A N/A nivolumab Opdivo Bristol-Myers-Squibb Canada N/A N/A nusinersen Spinraza Biogen Canada Inc. N/A Yes obeticholic acid Ocaliva Intercept Pharmaceuticals Inc. N/A N/A obinutuzumab Gazyva Hoffmann-La Roche Limited N/A N/A ocrelizumab Ocrevus Hoffmann-La Roche Limited N/A N/A Page 11 of
12 Products for Human Use - Active Period Register Of s File" ocriplasmin Jetrea ThromboGenics N.V. N/A N/A ofatumumab Arzerra Novartis Pharmaceuticals Canada Inc. N/A N/A olaparib Lynparza AstraZeneca Canada Inc. N/A N/A olaratumab Lartruvo Eli Lilly Canada Inc. N/A N/A olodaterol hydrochloride Striverdi Respimat Boehringer Ingelheim (Canada) Ltd. Inspiolto Respimat N/A ombitasvir, paritaprevir, dasabuvir sodium Holkira Pak Abbvie Corporation Technivie N/A osimertinib mesylate Tagrisso AstraZeneca Canada Inc. N/A N/A ozenoxacin Ozanex Ferrer Internacional, S.A. N/A Yes palbociclib Ibrance Pfizer Canada Inc. N/A N/A palonosetron hydrochloride Aloxi Purdue Pharma Akynzeo N/A pasireotide diaspartate Signifor Novartis Pharmaceuticals Canada Inc. Signifor Lar N/A patiromer sorbitex calcium Veltassa Vifor Fresenius Medical Care Renal Pharma Ltd. N/A N/A peginterferon beta-1a Plegridy Biogen Idec Canada Inc. N/A N/A pembrolizumab Keytruda Merck Canada Inc. N/A Yes peramivir Rapivab BioCryst Pharmaceuticals Inc. N/A N/A perampanel Fycompa Eisai Limited N/A Yes pertuzumab Perjeta Hoffmann-La Roche Limited Perjeta-Herceptin Combo Pack N/A Page 12 of
13 Products for Human Use - Active Period Register Of s File" pirfenidone Esbriet Hoffmann-La Roche Limited N/A N/A plerixafor Mozobil Sanofi-aventis Canada Inc. N/A N/A polidocanol Varithena Provensis Ltd. N/A N/A pomalidomide Pomalyst Celgene Inc. N/A N/A ponatinib hydrochloride Iclusig Ariad Pharmaceuticals Inc. N/A N/A pralatrexate Folotyn Servier Canada Inc. N/A N/A propiverine hydrochloride Mictoryl / Mictoryl Duchesnay Inc. N/A Yes prucalopride succinate Resotran Janssen Inc. N/A N/A radium dichloride Xofigo Bayer Inc. N/A N/A ramucirumab Cyramza Eli Lilly Canada Inc. N/A N/A recombinant human papillomavirus types 31, 33, 45, 52 and Gardasil 9 Merck Canada Inc. N/A Yes recombinant neisseria meningitidis group B NHBA fusion protein, recombinant neisseria meningitidis group B NadA fusion protein, recombinant neisseria meningitidis group B FHBP fusion protein, outer membrane vesicle (neisseria meningitidis group B NZ98/254 strain) Bexsero GlaxoSmithKline Inc. N/A Yes Page 13 of
14 Products for Human Use - Active Period recombinant porcine factor VIII (antihemophilic factor (recombinant), porcine sequence) Register Of s File" Obizur Shire Pharma Canada ULC N/A N/A regorafenib monohydrate Stivarga Bayer Inc. N/A N/A remestemcel-l Prochymal Osiris Therapeutics Inc. N/A Yes reslizumab Cinqair Teva Canada Limited N/A Yes ribociclib (supplied as ribociclib succinate) Kisqali Novartis Pharmaceuticals Canada Inc. N/A N/A rifaximin Zaxine Salix Pharmaceuticals Inc. N/A N/A rilpivirine hydrochloride Edurant Janssen Inc. Complera Odefsey Juluca Yes riociguat Adempas Bayer Inc. N/A N/A romidepsin Istodax Celgene Inc. N/A N/A rotigotine Neupro UCB Canada Inc. N/A N/A rubidium 82 chloride Ruby-Fill Jubilant Draximage Inc. N/A N/A rufinamide Banzel Eisai Limited N/A Yes rupatadine (supplied as rupatadine fumarate) Rupall Pediapharm Inc. N/A Yes ruxolitinib phosphate Jakavi Novartis Pharmaceuticals Canada Inc. N/A N/A sacubitril Entresto Novartis Pharmaceuticals Canada Inc. N/A N/A Page 14 of
15 Products for Human Use - Active Period Register Of s File" sarilumab Kevzara Sanofi-aventis Canada Inc. N/A N/A sebelipase alfa Kanuma Alexion Pharma GmbH N/A Yes secukinumab Cosentyx Novartis Pharmaceuticals Canada Inc. N/A N/A selexipag Uptravi Janssen Inc. N/A N/A semaglutide Ozempic Novo Nordisk Canada Inc. N/A N/A silodosin Rapaflo Purdue Pharma N/A N/A siltuximab Sylvant Janssen Inc. N/A N/A simeprevir Galexos Janssen Inc. N/A N/A sodium fluoride 18F NaF Plus Isologic Innovative Radiopharmaceuticals Ltd. N/A N/A sofosbuvir Sovaldi Gilead Sciences Canada Inc. Harvoni Epclusa Vosevi N/A stiripentol Diacomit Biocodex SA N/A Yes sucroferric oxyhydroxide Velphoro Vifor Fresenius Medical Care Renal Pharma Ltd. N/A N/A sugammadex sodium Bridion Merck Canada Inc. N/A N/A suvorexant Belsomra Merck Canada Inc. N/A N/A tafluprost Saflutan Purdue Pharma N/A N/A Page 15 of
16 Products for Human Use - Active Period Register Of s File" taliglucerase alfa Elelyso Pfizer Canada Inc. N/A Yes tedizolid phosphate Sivextro Merck Canada Inc. N/A N/A teduglutide Revestive Shire Pharmaceuticals Ireland Limited N/A N/A telaprevir Incivek Vertex Pharmaceuticals (Canada) Inc. N/A N/A telotristat ethyl (as telotristat etiprate) Xermelo Ipsen Biopharmaceuticals Canada Inc. N/A N/A tenofovir alafenamide hemifumarate Genvoya Gilead Sciences Canada Inc. Descovy Odefsey Vemlidy Symtuza Biktarvy teriflunomide Aubagio Genzyme Canada a division of Sanofiaventis Canada Inc Yes N/A N/A tesamorelin Egrifta Theratechnologies Inc. N/A N/A tezacaftor Symdeko Vertex Pharmaceuticals (Canada) Incorporated N/A Yes ticagrelor Brilinta AstraZeneca Canada Incorporated N/A N/A tisagenlecleucel / Kymriah Novartis Pharmaceuticals Canada Inc. N/A Yes tofacitinib Xeljanz Pfizer Canada Inc. N/A N/A tolvaptan Samsca Otsuka Pharmaceutical Co. Ltd. Jinarc N/A trametinib Mekinist Novartis Pharmaceuticals Canada Inc. N/A N/A Page 16 of
17 Products for Human Use - Active Period Register Of s File" trastuzumab emtansine Kadcyla Hoffmann-La Roche Limited N/A N/A trifluridine, tipiracil hydrochloride Lonsurf Taiho Pharma Canada Inc. N/A N/A turoctocog alfa Zonovate Novo Nordisk Canada Inc. N/A Yes ulipristal acetate Fibristal Allergan Inc. N/A N/A umeclidinium bromide Anoro Ellipta GlaxoSmithKline Inc. Incruse Ellipta N/A vandetanib Caprelsa Genzyme Canada, a division of Sanofiaventis Canada Inc. N/A N/A varicella-zoster virus glycoprotein E (ge) Shingrix GlaxoSmithKline Inc. N/A N/A vedolizumab Entyvio Takeda Canada Inc. N/A N/A velaglucerase alfa Vpriv Shire Human Genetic Therapies, Inc. N/A Yes velpatasvir Epclusa Gilead Sciences Canada Inc. Vosevi N/A vemurafenib Zelboraf Hoffmann-La Roche Ltd. N/A N/A venetoclax Venclexta AbbVie Corporation N/A N/A vernakalant hydrochloride Brinavess Cipher Pharmaceuticals Inc. N/A N/A vilanterol trifenatate Breo Ellipta GlaxoSmithKline Inc. Anoro Ellipta Trelegy Ellipta Yes vilazodone hydrochloride Viibryd Forest Laboratories Canada Inc. N/A N/A Page 17 of
18 Products for Human Use - Active Period Register Of s File" vismodegib Erivedge Hoffmann-La Roche Ltd. N/A N/A vorapaxar sulfate Zontivity Aralez Pharmaceuticals Trading DAC N/A N/A vortioxetine hydrobromide Trintellix Lundbeck Canada Inc. N/A Yes voxilaprevir Vosevi Gilead Sciences Canada Inc. N/A N/A *The medicinal ingredient not previously approved in a drug by the Minister and that is not a variation of a previously approved medicinal ingredient (subsection C (1) of the Food and Drug Regulations ). Page 18 of
19 Products for Human Use - Expired Period Register Of s File" abatacept Orencia Bristol-Myers Squibb Canada N/A Yes acamprosate calcium Campral Mylan Pharmaceuticals ULC N/A N/A alglucosidase alfa Myozyme Genzyme Canada Inc. N/A Yes aliskiren hemifumarate Rasilez Novartis Pharmaceuticals Canada Inc. Rasilez HCT Rasilamlo N/A ambrisentan Volibris GlaxoSmithKline Inc. N/A N/A anidulafungin Eraxis Pfizer Canada Inc. N/A Yes aprepitant Emend Merck Frosst Canada Ltd. Emend Tri-Pack Emend IV N/A aripiprazole Abilify Bristol-Myers Squibb Canada Abilify Maintena Yes azacitidine Vidaza Celgene N/A N/A besifloxacin Besivance Bausch & Lomb Inc. N/A Yes canakinumab Ilaris Novartis Pharmaceuticals Canada Inc. N/A Yes ceftobiprole medocaril Zeftera Janssen Inc. N/A N/A certolizumab pegol Cimzia UCB Canada Inc. N/A N/A ciclesonide Alvesco Takeda Canada Inc. Omnaris Omnaris HFA Yes clofarabine Clolar Sanofi-aventis Canada Inc. N/A Yes dabigatran etexilate mesilate Pradaxa Boehringer Ingelheim (Canada) Ltd. N/A N/A Page 19 of
20 Products for Human Use - Expired Period Register Of s File" daptomycin Cubicin Cubist Pharmaceuticals, Incorporated N/A Yes darunavir ethanolate Prezista Janssen Inc. N/A Yes dasatinib monohydrate Sprycel Bristol-Myers Squibb Canada N/A N/A deferasirox Exjade Novartis Pharmaceuticals Canada Inc. N/A Yes degarelix acetate Firmagon Ferring Inc. N/A N/A denosumab Prolia Amgen Canada Inc. Xgeva N/A desvenlafaxine succinate Pristiq Pfizer Canada Inc. N/A Yes dexmedetomidine hydrochloride Precedex Pfizer Canada Inc. N/A Yes doripenem monohydrate Doribax Janssen Inc. N/A N/A dronedarone hydrochloride Multaq Sanofi-aventis Canada Inc. N/A N/A duloxetine hydrochloride Cymbalta Eli Lilly Canada Inc. N/A Yes eculizumab Soliris Alexion Pharma International Sàrl N/A Yes eplerenone Inspra Pfizer Canada Inc. N/A Yes etravirine Intelence Janssen Inc. N/A Yes everolimus Afinitor Novartis Pharmaceuticals Canada Inc. Certican Yes febuxostat Uloric Takeda Canada Inc. N/A N/A fludeoxyglucose 18F Cantrace Ipet Pharmaceuticals Inc. N/A N/A fluticasone furoate Avamys GlaxoSmithKline Inc. N/A Yes Page 20 of
21 Products for Human Use - Expired Period Register Of s File" gadofosveset trisodium Vasovist Berlex Canada Inc. N/A N/A gadoxetate disodium Primovist Bayer Inc. N/A N/A golimumab Simponi Janssen Inc. N/A N/A human C1 esterase inhibitor Berinert CSL Behring Canada Inc. Haegarda N/A idebenone Catena Santhera Pharmaceuticals Ltd. N/A Yes idursulfase Elaprase Shire Human Genetic Therapies, Inc. N/A Yes influenza virus type A (H1N1), influenza virus type A (H3N2), influenza virus type B FluMist AstraZeneca Canada Incorporated FluMist Quadrivalent Yes lacosamide Vimpat UCB Canada Inc. N/A N/A lanreotide Somatuline Autogel Ipsen Biopharm Limited N/A N/A lanthanum carbonate Fosrenol Shire BioChem Inc. N/A N/A lapatinib ditosylate Tykerb Novartis Pharmaceuticals Canada Inc. N/A N/A lenalidomide Revlimid Celgene N/A N/A liraglutide Victoza Novo Nordisk Canada Inc. Saxenda Xultophy N/A lisdexamfetamine dimesylate Vyvanse Shire Pharma Canada ULC. N/A Yes loteprednol etabonate Alrex Bausch & Lomb Inc. Lotemax Lotemax Ointment Lotemax Gel N/A lumiracoxib Prexige Novartis Pharmaceuticals Canada Inc. N/A N/A maraviroc Celsentri ViiV Healthcare ULC N/A N/A Page 21 of
22 Products for Human Use - Expired Period methoxy polyethylene gycol epoetin beta Register Of s File" Mircera Hoffmann-La Roche Ltd. N/A N/A methylnaltrexone bromide Relistor Salix Pharmaceuticals, Inc. N/A N/A micafungin sodium Mycamine Astellas Pharma Canada, Inc. N/A N/A natalizumab Tysabri Biogen Idec Canada Inc. N/A N/A nelarabine Atriance Novartis Pharmaceuticals Canada Inc. N/A Yes nepafenac Nevanac Alcon Canada Inc. Ilevro N/A nesiritide Natrecor Janssen Inc. N/A N/A nilotinib hydrochloride monohydrate Tasigna Novartis Pharmaceuticals Canada Inc. N/A N/A olmesartan medoxomil Olmetec Merck Canada Inc. Olmetec Plus Yes oxaliplatin Eloxatin Sanofi-aventis Canada Inc. N/A Yes paliperidone Invega Janssen Inc. Invega Sustenna Yes panitumumab Vectibix Amgen Canada Inc. N/A N/A pazopanib hydrochloride Votrient Novartis Pharmaceuticals Canada Inc. N/A N/A pneumococcal polysaccharide serotype 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, 23F Synflorix GlaxoSmithKline Inc. N/A Yes pneumococcal polysaccharide serotype 3, 5, 6A, 19A, Prevnar 13 Pfizer Canada Inc. N/A Yes posaconazole Posanol Merck Canada Inc. N/A Yes Page 22 of
23 Products for Human Use - Expired Period Register Of s File" prasugrel hydrochloride Effient Eli Lilly Canada Inc. N/A Yes raltegravir potassium Isentress Merck Frosst Canada Inc. N/A Yes ranibizumab Lucentis Novartis Opthalmics, Novartis Pharmaceuticals N/A N/A rasagiline mesylate Azilect Teva Pharmaceuticals Industries Ltd. N/A N/A recombinant human papillomavirus type 11 L1, type 16 L1, type 18 L1 & type 6 L1 protein Gardasil Merck Frosst Canada Ltd. N/A Yes retapamulin Altargo GlaxoSmithKline Inc. N/A Yes rivaroxaban Xarelto Bayer Healthcare N/A N/A roflumilast Daxas Takeda Canada Inc. N/A N/A romiplostim Nplate Amgen Canada Inc. N/A Yes rotavirus RIX4414 strain, live, attenuated (human) Rotarix GlaxoSmithKline Inc. N/A Yes rotavirus vaccine, live, oral type G1, type G2, type G3, type G4 & type P1(8) (human) Rotateq Merck Frosst Canada Ltd. N/A Yes sapropterin dihydrochloride Kuvan BioMarin Pharmaceutical Inc. N/A Yes saxagliptin hydrochloride Onglyza AstraZeneca Canada Inc. Komboglyze Qtern sitagliptin phosphate Januvia Merck Frosst Canada Ltd. Janumet Janumet XR N/A N/A Page 23 of
24 Products for Human Use - Expired Period Register Of s File" sitaxsentan sodium Thelin Pfizer Canada Inc. N/A N/A sorafenib Nexavar Bayer Inc. N/A N/A tapentadol hydrochloride Nucynta CR Janssen Inc. Nucynta IR Nucynta Extended Release N/A telavancin hydrochloride Vibativ Pendopharm Division of de Pharmascience Inc. N/A N/A telbivudine Sebivo Novartis Pharmaceuticals Canada Inc. N/A N/A temsirolimus Torisel Pfizer Canada Inc. N/A Yes tigecycline Tygacil Pfizer Canada Inc. N/A N/A tocilizumab Actemra Hoffmann-La Roche Ltd. N/A Yes trabectedin Yondelis Janssen Inc. N/A N/A ustekinumab Stelara Janssen Inc. N/A N/A varenicline tartrate Champix Pfizer Canada Inc. N/A Yes vorinostat Zolinza Merck Frosst Canada Ltd. N/A N/A ziprasidone hydrochloride monohydrate Zeldox Pfizer Canada Inc. N/A Yes zucapsaicin Zuacta Sanofi-aventis Canada Inc. N/A N/A *The medicinal ingredient not previously approved in a drug by the Minister and that is not a variation of a previously approved medicinal ingredient (subsection C (1) of the Food and Drug Regulations). Page 24 of
25 Products for Veterinary Use - Active Period Register Of s File" afoxolaner Nexgard Merial Canada Inc. Nexgard Spectra avilamycin Surmax 100 Premix Elanco Canada Limited Surmax 200 Premix cefpodoxime proxetil Simplicef Zoetis Canada Inc. N/A clodronate disodium tetrahydrate Osphos Injection Dechra Ltd. N/A closantel sodium Flukiver Elanco Division Eli Lilly Canada Inc N/A derquantel Startect Zoetis Canada Inc. N/A dibotermin alfa (rhbmp-2) Truscient Zoetis Canada Inc. N/A fluralaner Bravecto Intervet Canada Corp. N/A gonadotropin releasing factor analogue - protein conjugate insulin human (recombinant) Improvest Zoetis Canada Inc. N/A Prozinc Boehringer Ingelheim Canada Ltd. N/A lotilaner Credelio Elanco Canada Limited N/A lubabegron Experior Elanco Canada Limited N/A oclacitinib maleate Apoquel Zoetis Canada Inc. N/A peforelin Maprelin XP-10 Modern Veterinary Therapeutics LLC N/A pegbovigrastim Imrestor Elanco Division Eli Lilly Canada Inc. N/A Page 25 of
26 Products for Veterinary Use - Active Period Register Of s File" pergolide mesylate Prascend Boehringer Ingelheim Canada Ltd. N/A permethrin Oridermyl Vétoquinol N.- A Inc. N/A phenobarbital Epiphen Vétoquinol N.- A Inc. N/A pradofloxacin Veraflox Bayer Inc., Bayer Healthcare, Animal Health N/A robenacoxib Onsior Elanco Canada Limited N/A sarolaner Simparica Zoetis Canada Inc. Revolution Plus telmisartan Semintra Boehringer Ingelheim Canada Ltd. N/A terbinafine Osurnia Elanco Canada Limited N/A tildipirosin Zuprevo Intervet Canada Corp. N/A tiludronic acid (as tiludronate disodium) triptorelin (as triptorelin acetate) Tildren CEVA Animal Health N/A Ovugel United-AH II, LLC N/A *The medicinal ingredient not previously approved in a drug by the Minister and that is not a variation of a previously approved medicinal ingredient (subsection C (1) of the Food and Drug Regulations). Page 26 of
27 Products for Veterinary Use - Expired Period Register Of s File" acetaminophen Pracetam 20% O.S. Ceva Animal Health Inc. N/A buprenorphine hydrochloride Vetergesic Multidose Sogeval UK Limited N/A cefovecin sodium Convenia Zoetis Canada Inc. N/A cephalexin monohydrate Vetolexin Vétoquinol N.-A Inc. Cefaseptin dirlotapide Slentrol Zoetis Canada Inc. N/A emamectin benzoate Slice Intervet Canada Ltd. N/A emodepside / / firocoxib / fluoxetine hydrochloride / / Profender Bayer Healthcare, Animal Health Division N/A Previcox Merial Canada Inc. N/A Reconcile Elanco, Division Eli Lilly Canada Inc. N/A gamithromycin Zactran Merial Canada Inc. N/A ibafloxacin / imidapril hydrochloride / / Ibaflin gel Intervet Canada Ltd. N/A Prilium Vétoquinol N.-A Inc. N/A itraconazole Itrafungol Elanco, Division Eli Lilly Canada Inc. N/A Page 27 of
28 Products for Veterinary Use - Expired Period maropitant / / / Register Of s File" Cerenia Zoetis Canada Inc. N/A mitratapide Yarvitan Janssen Pharmaceutica N.V. N/A mometasone furoate monohydrate Mometamax Intervet Canada Corp. N/A ramipril / / Vasotop Intervet Canada Ltd. N/A sevoflurane Sevoflo Zoetis Canada Inc. N/A spinosad / / / / tepoxalin / / Comfortis Elanco, Division Eli Lilly Canada Inc. Trifexis Zubrin Schering Plough Canada Inc. N/A thiamazole Felimazole Dechra Ltd. N/A toceranib phosphate Palladia Zoetis Canada Inc. N/A toltrazuril Baycox Bayer Inc., Bayer Healthcare Animal Health Division N/A Page 28 of
29 Products for Veterinary Use - Expired Period trilostane / / / Register Of s File" Vetoryl Dechra Ltd. N/A tulathromycin Draxxin Pfizer Canada Inc., Animal Health Group N/A zilpaterol hydrochloride Zilmax Intervet Canada Ltd. N/A *The medicinal ingredient not previously approved in a drug by the Minister and that is not a variation of a previously approved medicinal ingredient (subsection C (1) of the Food and Drug Regulations). The Minister of Health maintains a register of innovative drugs pursuant to sub-section C (9) of the Food and Drug Regulations. Page 29 of
Information for Vermont Prescribers of Prescription Drugs (Long Form)
Information for Vermont Prescribers of Prescription Drugs (Long Form) LONSURF (tipiracil and trifluridine) tablets This list does not imply that the products on this chart are interchangeable or have the
More informationIPR Rituxan 8,545,843 2-Nov-17 Pfizer, Inc. Biogen, Inc. Denied Pending N/A
Trial Drug (if applicable) Patent No. Filed Date Petitioner(s) Patent Owner(s) Inst. Dec. Outcome Details of FWD
More informationFoundation; Initiative for Medicines, Access & Eli Lilly & Co.; Avid. Vosevi 7,429, Oct-17
Trial Drug (if applicable) Patent No. Filed Date Petitioner(s) Patent Owner(s) Inst. Dec. Outcome Details of FWD
More informationDrug - Brand Name (Generic Name) Oseni (alogliptin / pioglitazone) - PA. Obizur (antihemophilic factor, recombinant, porcine sequence-obizur)
Orencia (abatacept) - PA Oseni (alogliptin / pioglitazone) - PA Obizur (antihemophilic factor, recombinant, porcine sequence-obizur) Otezla (apremilast) - PA Olumiant (baricitinib) - PA Omnaris (ciclesonide
More informationAS~va ~3rJ(~t2. . An: l8\ npoe; roue. rev.f!.jvoi1 OpyavWOI1e; & ~XEOLUOIlOUAyopae; YRI1PEOlWVYydae;, f!.jvol1 CDapllaKou, TIl~lla
EAAHNIKH L\HMOKPATIA npoe; roue krrpucouc ~umoyoue; rnc Xwpae; AS~va ~3rJ(~t2. An: l8\ Kupla/E npoeope, ~ae;ola~l~a~ouile Eyypacj>o rou ESVlKOU Opyavlollou napox~e; YRI1PEOlWVYYElae;, rev.f!.jvoi1 OpyavWOI1e;
More informationBCN Advantage Formulary Updates: April, 2018
Attention BCN Advantage members: This is a list of changes made to the BCN Advantage formulary since its initial release in October, 2017 BCN Advantage may add or remove drugs from our formulary during
More informationIPR ,318, Dec-13 PRISM Pharma Co., Ltd. CHOONGWAE PHARMA CORP. N/A Settled pre-institution N/A
Trial Drug (if applicable) Patent No. Filed Date Petitioner(s) Patent Owner(s) Inst. Dec. Outcome Details of FWD
More informationPHYSICIANS HEALTH PLAN NOTIFICATION/PRIOR AUTHORIZATION TABLE-ALL PRODUCTS
PHP Notification/Prior Authorization/Prior Approval Table-All Products Effective April 1, 2014. SERVICES / ITEMS / PROCEDURES Abortion services **** N/A **** N/A N/A N/A **** N/A **** N/A **** N/A ****
More informationAcyclovir Ointment. Aetna Better Health Louisiana. Products Affected. acyclovir ointment 5 % external Details. Criteria
Acyclovir Ointment acyclovir ointment 5 % external Aetna Better Health Louisiana Use of oral acyclovir in the previous 130 days 1 Adcirca ADCIRCA TABLET 20 MG ORAL Use of sildenafil in previous 30 days
More information2019 Service Benefit Plan FEP Blue Focus Specialty Drug List
2019 Service Benefit Plan FEP Blue Focus Specialty Drug List If you are a member or health care provider and have questions, please call 1-888-346-3731, or visit fepblue.org/pharmacy. Specialty drugs are
More informationBALTIC STATES PHARMA MARKET OVERVIEW. Secondary sales analysis
BALTIC STATES PHARMA MARKET OVERVIEW Secondary sales analysis Content Introduction General overview Sales dynamics in Baltic states 2009 2014 Generic / Originator drugs market share in Baltic states 2013
More informationProvider Partners Pennsylvania Advantage Plan Offered by Provider Partners Health Plan April 2019 Formulary Addendum
Provider Partners Pennsylvania Advantage Plan Offered by Provider Partners Health Plan April 2019 Formulary Addendum Below is a list formulary changes for the benefit year 2019. This is not a complete
More information2018 Service Benefit Plan Specialty Drug List
2018 Service Benefit Plan Specialty Drug List If you are a member or health care provider and have questions, please call 1-888-346-3731, or visit fepblue.org/pharmacy. Specialty drugs are prescribed to
More informationCurrent as of November 1, 2017
Current as of November 1, 2017 ZYTIGA 500 MG ORAL TABLETS Formulary Addition TIER 5 QL = 2 PER DAY BENLYSTA 200 MG/ML AUTO- INJECTOR Formulary Addition TIER 5 BENLYSTA 200 MG/ML PREFILLED SYRINGE Formulary
More informationQuick Reference Guide
Quick Reference Guide Medication (Medical Benefit) Prior Approval Requirements 2018 MedicationsPA-00-02-110117 Effective 1/1/18 Medication (Medical Benefit) Coverage Guidelines This guide provides an overview
More informationCare Wisconsin 2018 Formulary Addendum
pharmacies, - Non-Formulary, PA - Prior Authorization, QL Quantity Limit per 30 days, ST - Step Therapy EFFECTIVE 01/01/ 0.5 ML SUMATRIPTAN 4 MG CARTRIDGE 0.5 ML SUMATRIPTAN 6 MG Last Updated: 03/24/ Effective
More informationAcyclovir Ointment. Aetna Better Health Kentucky. Products Affected. acyclovir ointment 5 % external Details. Criteria
Acyclovir Ointment acyclovir ointment 5 % external Aetna Better Health Kentucky Use of oral acyclovir or Abreva in the previous 130 days 1 Adcirca ADCIRCA TABLET 20 MG ORAL Use of sildenafil in previous
More informationAcyclovir Ointment. Aetna Better Health New Jersey. Products Affected. acyclovir ointment 5 % external Details. Criteria
Acyclovir Ointment acyclovir ointment 5 % external Aetna Better Health New Jersey Use of oral acyclovir or Abreva in the previous 130 days 1 Adcirca tadalafil (pah) tablet 20 mg oral Use of sildenafil
More informationMemorial Hermann Advantage HMO November 2015 Formulary Addendum
Memorial Hermann Advantage HMO November 2015 Formulary Addendum Changes may have occurred since the printing of your current Medicare Advantage HMO Formulary. Medications may have been added or removed
More informationAcyclovir Ointment. Aetna Better Health Virginia Medallion/FAMIS 3.0. Products Affected. acyclovir ointment 5 % external Details.
Aetna Better Health Virginia Medallion/FAMIS 3.0 Acyclovir Ointment acyclovir ointment 5 % external Use of oral acyclovir in the previous 130 days 1 Adcirca tadalafil (pah) tablet 20 mg oral Use of sildenafil
More informationUpcoming Changes to Retiree RxCare s 5 Tier Formulary
Upcoming Changes to Retiree RxCare s 5 Tier Formulary Retiree RxCare may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, [or] add prior authorization, quantity
More informationSPONSORSHIP 2008 guide
SPONSORSHIP 2008guide Prix Galien USA Committee Michael S. Brown, M.D. Professor of Molecular Genetics and Internal Medicine, UT Southwestern Medical Center at Dallas Prix Galien in the wor l d Prix Galien
More informationTexas Medicaid April 26, 2019 Meeting
ABBVIE US LLC CREON (ORAL) PANCREATIC ENZYMES ABBVIE US LLC DUOPA (MISCELL) ANTIPARKINSON'S AGENTS ABBVIE US LLC HUMIRA KIT (INJECTION) CYTOKINE AND CAM ANTAGONISTS ABBVIE US LLC HUMIRA PEN KIT (INJECTION)
More informationMemorial Hermann Advantage HMO & PPO April 2018 Formulary Addendum
Memorial Hermann Advantage HMO & PPO April 2018 Formulary Addendum Changes may have occurred since the printing of your current Memorial Hermann Advantage HMO & PPO Formulary. Medications that may have
More informationTexas Drug Utilization Review April 28, 2017 Meeting
Texas Drug Utilization Review Meeting ABBVIE US LLC CREON (ORAL) PANCREATIC ENZYMES ABBVIE US LLC DUOPA (MISCELL) ANTIPARKINSON'S AGENTS ABBVIE US LLC NIASPAN (ORAL) LIPOTROPICS, OTHER ABBVIE US LLC TECHNIVIE
More informationName of Company Involved. Exact or Estimated Value. Accepted / Refused
202 Simon Duckett Cardiology Consultant 25/09/2017 Sponsorship 232 N/A N/A N/A 06/11/2017 Sponsorship 241 N/A N/A N/A 14/11/2017 Sponsorship 245 N/A N/A N/A 17/11/2017 Sponsorship 246 N/A N/A N/A 17/11/2017
More informationMANUFACTURER BRAND NAME THERAPEUTIC CLASS
ABBVIE US LLC CREON (ORAL) PANCREATIC ENZYMES ABBVIE US LLC DUOPA (MISCELL) ANTIPARKINSON'S AGENTS ABBVIE US LLC NIASPAN (ORAL) LIPOTROPICS, OTHER ABBVIE US LLC TRICOR (ORAL) LIPOTROPICS, OTHER ABBVIE
More informationTennCare Product List
ABBVIE US LLC ADVICOR (ORAL) LIPOTROPICS, STATINS ABBVIE US LLC ANDROGEL GEL PACKET (TRANSDERM.) ANDROGENIC AGENTS ABBVIE US LLC ANDROGEL GEL PUMP (TRANSDERM) ANDROGENIC AGENTS ABBVIE US LLC CREON (ORAL)
More informationTexas Medicaid April 2016
ABBVIE US LLC ADVICOR (ORAL) LIPOTROPICS, STATINS ABBVIE US LLC CREON (ORAL) PANCREATIC ENZYMES ABBVIE US LLC DUOPA (MISCELL) ANTIPARKINSON'S AGENTS ABBVIE US LLC NIASPAN (ORAL) LIPOTROPICS, OTHER ABBVIE
More informationWIDE MOAT INVESTMENT SUMMIT 2014 ZOETIS
WIDE MOAT INVESTMENT SUMMIT 2014 ZOETIS 60 Commerce Drive Wyomissing, PA 19610 www.lountzis.com JULY 2014 1 PRESENTATION OUTLINE INVESTMENT THESIS COMPANY HISTORY ANIMAL HEALTH INDUSTRY DYNAMICS BUSINESSSES
More informationMANUFACTURER BRAND NAME THERAPEUTIC CLASS
ABBVIE US LLC DUOPA (MISCELL) ANTIPARKINSON'S AGENTS ABBVIE US LLC HUMIRA KIT (INJECTION) CYTOKINE AND CAM ANTAGONISTS ABBVIE US LLC HUMIRA PEN KIT (INJECTION) CYTOKINE AND CAM ANTAGONISTS ABBVIE US LLC
More informationUPDATED RANKING LIST
Current RK2014 RK2013 AMS14 Roche Fresenius Medical Care 1.292,00 67,00 1.359,00 1.215,50 124,00 1.339,50 Baxter - Gambro Renal (former Gambro) 1.070,50 98,00 1.168,50 Amgen 1.016,00 71,50 1.087,50 Janssen
More informationCare Wisconsin 2017 Formulary Addendum
- Non-Formulary, PA - Prior Authorization, HR High Risk Medication, QL Quantity Limit per 30 days, EFFECTIVE 01/01/ ABILIFY MAINT INJ 400 1/26 + ST2 Formulary Enhancement N/A ABILIFY MAINT SUSP 300 1/26
More informationPayment Allowance Limits for Medicare Part B Drugs. Effective July 1, 2018 through September 30, 2018
Payment Allowance Limits for Medicare Part B Drugs Effective July 1, 2018 through September 30, 2018 Note 1: Payment allowance limits subject to the ASP methodology are based on 1Q18 ASP data. Note 2:
More informationPayment Allowance Limits for Medicare Part B Drugs. Effective January 1, 2018 through March 31, 2018
Payment Allowance Limits for Medicare Part B Drugs Effective January 1, 2018 through March 31, 2018 Note 1: Payment allowance limits subject to the ASP methodology are based on 3Q17 ASP data. Note 2: The
More informationMagellan Medicaid Administration - TOP$
ABBVIE US LLC ANDROGEL GEL PACKET (TRANSDERM.) ANDROGENIC AGENTS ABBVIE US LLC ANDROGEL GEL PUMP (TRANSDERM) ANDROGENIC AGENTS ABBVIE US LLC CREON (ORAL) PANCREATIC ENZYMES ABBVIE US LLC KALETRA SOLUTION
More informationMANUFACTURER BRAND NAME THERAPEUTIC CLASS
ABBVIE US LLC ANDROGEL GEL PACKET (TRANSDERM.) ANDROGENIC AGENTS ABBVIE US LLC ANDROGEL GEL PUMP (TRANSDERM) ANDROGENIC AGENTS ABBVIE US LLC CREON (ORAL) PANCREATIC ENZYMES ABBVIE US LLC KALETRA SOLUTION
More informationS P O N S O R S H I P G U I D E
S P O N S O R S H I P G U I D E Innovation to Improve the Human Condition The Prix Galien Award recognizes outstanding achievements in improving the global human condition through the development of innovative
More informationPayment Allowance Limits for Medicare Part B Drugs. Effective April 1, 2018 through June 30, 2018
Payment Allowance Limits for Medicare Part B Drugs Effective April 1, 2018 through June 30, 2018 Note 1: Payment allowance limits subject to the ASP methodology are based on 4Q17 ASP data. Note 2: The
More informationPayment Allowance Limits for Medicare Part B Drugs. Effective October 1, 2017 through December 31, 2017
90371 Hep b ig im 1 ML 124.273 90375 Rabies ig im/sc 150 IU 314.271 90376 Rabies ig heat treated 150 IU 317.428 90585 Bcg vaccine percut 50 MG 131.252 90586 Bcg vaccine intravesical 1 EACH 131.252 Limit
More informationPayment Allowance Limits for Medicare Part B Drugs. Effective January 1, 2019 through March 31, 2019
Payment Allowance Limits for Medicare Part B Drugs Effective January 1, 2019 through March 31, 2019 Note 1: Payment allowance limits subject to the ASP methodology are based on 3Q18 ASP data. Note 2: The
More informationPayment Allowance Limits for Medicare Part B Drugs. Effective April 1, 2017 through June 30, 2017
Payment Allowance Limits for Medicare Part B Drugs Effective April 1, 2017 through June 30, 2017 Note 1: Payment allowance limits subject to the ASP methodology are based on 4Q16 ASP data. Note 2: The
More informationPayment Allowance Limits for Medicare Part B Drugs. Effective July 1, 2017 through September 30, 2017
Payment Allowance Limits for Medicare Part B Drugs Effective July 1, 2017 through September 30, 2017 Note 1: Payment allowance limits subject to the ASP methodology are based on 1Q17 ASP data. Note 2:
More informationPayment Allowance Limits for Medicare Part B Drugs. Effective October 1, 2017 through December 31, 2017
Payment Allowance Limits for Medicare Part B Drugs Effective October 1, 2017 through December 31, 2017 Note 1: Payment allowance limits subject to the ASP methodology are based on 2Q17 ASP data. Note 2:
More informationMANUFACTURER BRAND NAME THERAPEUTIC CLASS
ABBVIE US LLC ANDROGEL GEL PACKET (TRANSDERM.) ANDROGENIC AGENTS ABBVIE US LLC ANDROGEL GEL PUMP (TRANSDERM) ANDROGENIC AGENTS ABBVIE US LLC CREON (ORAL) PANCREATIC ENZYMES ABBVIE US LLC DUOPA (MISCELL)
More informationGeorgia Department of Community Health. May 2018 Meeting
ABBVIE US LLC ANDROGEL GEL PACKET (TRANSDERM.) ANDROGENIC AGENTS ABBVIE US LLC ANDROGEL GEL PUMP (TRANSDERM) ANDROGENIC AGENTS ABBVIE US LLC HUMIRA KIT (INJECTION) CYTOKINE AND CAM ANTAGONISTS ABBVIE US
More informationMO HealthNet September 2012 Meeting
ABBOTT ADVICOR (ORAL) LIPOTROPICS, STATINS ABBOTT CREON (ORAL) PANCREATIC ENZYMES ABBOTT HUMIRA KIT (INJECTION) CYTOKINE AND CAM ANTAGONISTS ABBOTT HUMIRA PEN IJ KIT (INJECTION) CYTOKINE AND CAM ANTAGONISTS
More informationMANUFACTURER BRAND NAME THERAPEUTIC CLASS
ABBVIE US LLC ADVICOR (ORAL) LIPOTROPICS, STATINS ABBVIE US LLC ANDROGEL GEL PACKET (TRANSDERM.) ANDROGENIC AGENTS ABBVIE US LLC ANDROGEL GEL PUMP (TRANSDERM) ANDROGENIC AGENTS ABBVIE US LLC CREON (ORAL)
More informationStep Therapy Criteria Last Updated 6/1/2018
Step Therapy Last Updated 6/1/2018 For information on obtaining an updated coverage determination or an exception to a coverage determination please call Freedom Health Member Services at 1-800-401-2740
More informationAgeWell 5-Tier 2017 Formulary Addendum
EFFECTIVE 01/01/ ABILIFY MAINT INJ 400MG ADRUCIL INJ 500/10ML NF 2 + BvD Formulary Enhancement N/A AMMONIUM LAC CRE 12% NF 1 Formulary Enhancement N/A AMMONIUM LAC LOT 12% 2 1 Formulary Enhancement N/A
More information2018 Year-to-date Formulary Additions and Deletions
Health Choice Generations may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, add prior authorization, quantity limits and/or step therapy restrictions on
More informationGenesis Clinical Research Tampa, FL Medical Director. Fresenius Medical Care Tampa, FL Medical Director. 10/31/1997 to Present
Jesus Ovidio Navarro, MD Genesis Clinical Research 4710 N Habana Avenue, Suite 300 Tampa, FL 33614 Phone: 813-873-1016 Fax: 813-879-1336 genclin@aol.com Licenses and Certifications: Florida ME 0057891
More informationMANUFACTURING PROBLEMS AS OF 20th June 2017
MANUFACTURING PROBLEMS AS OF 20th June If you know of any stock Issues that are not on this list please get in touch at ahope@nhs.net The information contained in this bulletin is based on information
More informationSchedule 1 Product Category Listing Revision Date:
Schedule 1 400 ACNE AGENTS, TOPICAL ACZONE (TOPICAL) ALLERGAN INC. 400 ACNE AGENTS, TOPICAL AVAR (TOPICAL) & AVAR LS (TOPICAL) MISSION PHARM. 400 ACNE AGENTS, TOPICAL CLINDACIN PAC KIT (TOPICAL) MEDIMETRIKS
More informationAgeWell 1-Tier 2017 Formulary Addendum
FORMULARY CHANGES EFFECTIVE 01/01/ ABILIFY MAINT INJ 400MG ADRUCIL INJ 500/10ML NF 1 + BvD Formulary Enhancement N/A AMMONIUM LAC CRE 12% BUPROPION TAB 150MG BUTAL/APAP TAB 50-325MG CAZIANT PAK CHOLESTYRAMINE
More informationVirginia Medicaid April 18, 2013
ABBVIE US LLC ANDROGEL GEL PACKET (TRANSDERM.) ANDROGENIC AGENTS ABBVIE US LLC ANDROGEL GEL PUMP (TRANSDERM) ANDROGENIC AGENTS ABBVIE US LLC HUMIRA KIT (INJECTION) CYTOKINE AND CAM ANTAGONISTS ABBVIE US
More informationPayment Allowance Limits for Medicare Part B Drugs Effective October 1, 2015 through December 31, 2015
Payment Allowance s for Medicare Part B Drugs HCPCS Code Short Description HCPCS Code Dosage Payment 90371 Hep b ig, im 1 ML 104.559 90375 Rabies ig, im/sc 150 IU 248.296 90376 Rabies ig, heat treated
More informationEnvisionRxPlus Formulary. (List of Covered Drugs)
EnvisionRxPlus 018 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN HPMS Approved Formulary File Submission 18365, Version Number
More informationTennCare Product List
ABBVIE US LLC ADVICOR (ORAL) LIPOTROPICS, STATINS ABBVIE US LLC ANDROGEL GEL PACKET (TRANSDERM.) ANDROGENIC AGENTS ABBVIE US LLC ANDROGEL GEL PUMP (TRANSDERM) ANDROGENIC AGENTS ABBVIE US LLC CARDIZEM LA
More informationTexas Medicaid April 2015
ABBVIE US LLC ADVICOR (ORAL) LIPOTROPICS, STATINS ABBVIE US LLC CREON (ORAL) PANCREATIC ENZYMES ABBVIE US LLC NIASPAN (ORAL) LIPOTROPICS, OTHER ABBVIE US LLC SIMCOR (ORAL) LIPOTROPICS, STATINS ABBVIE US
More informationATRIO Health Plans 2018 PPO Plans Formulary Change Notice
Formulary ID: 18032 ATRIO Bronze Rx (Basin) ATRIO Silver Rx ATRIO Gold Rx ATRIO Bronze Rx (Umpqua) ATRIO Bronze Rx (Rogue) ATRIO Silver Rx (Rogue) ATRIO Gold Rx (Willamette) ATRIO Silver Rx (Willamette)
More information2018 Year-to-date Formulary Additions
Health Choice Generations may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, add prior authorization, quantity limits and/or step therapy restrictions on
More informationPA Prior authorization ST Step therapy QL Quantity limit AE Age Edit. More Details. Last Updated: April 1,
Preventive Drug List Preventive drugs are used to help avoid disease and maintain health. Some insurance plans have a benefit that allows you to buy preventive drugs at a copay. Check your plan details
More informationPA Prior authorization ST Step therapy QL Quantity limit AE Age Edit. Last Updated: January 1,
Preventive Drug List Preventive drugs are used to help avoid disease and maintain health. Some insurance plans have a benefit that allows you to buy preventive drugs at a copay. Check your plan details
More informationAMERICAN PSYCHIATRIC ASSOCIATION CONTINUING MEDICAL EDUCATION POLICY ON FULL DISCLOSURE
AMERICAN PSYCHIATRIC ASSOCIATION CONTINUING MEDICAL EDUCATION POLICY ON FULL DISCLOSURE The American Psychiatric Association requires disclosure, by presenters at CME activities, of any significant financial
More informationTOP$ MULTI-STATE DIVISIONS OF MEDICAID
MANUFACTURER BRAND NAME (ROUTE) THERAPEUTIC CLASS ABBOTT LABS. HUMIRA (INJECTION) CYTOKINE AND CAM ANTAGONISTS ADVANCED VISION NUTRIDOX (ORAL) TETRACYCLINES ALCON LABS. ALOMIDE (OPHTHALMIC) OPHTHALMICS
More informationProvider Partners Illinois Advantage Plan (HMO SNP) 2019 Formulary (List of Covered Drugs)
Provider Partners Illinois Advantage Plan (H SNP) 2019 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN Formulary ID 19547, Version
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Human, Recombinant) Reference Number: CP.CPA.76 Effective Date: 11.16.16 Last Review Date: 08.17 Line of Business: Medicaid Medi-Cal Revision Log See Important Reminder at the end of
More informationProfessional Providers
April 2007 Professional Providers Provider Bulletin Number 738b Quarterly HCPCS Updates The following Healthcare Common Procedure Coding System (HCPCS) codes are covered with an effective date of January
More information6.25 mg 1 tab, PO, BIDMEALS, Take with Meals, Duration: 30 day (DEF)*
DRUG AND TREATMENT Available at: BMC-B BMC-D BMC-N BMC-S Medications Antiarrhythmics amiodarone 200 mg oral tablet (Rx)* 200 mg 2 tab, PO, BID, Duration: 30 day (DEF)* 200 mg 2 tab, PO, BID, Duration:
More informationPA Prior authorization ST Step therapy QL Quantity limit AE Age Edit. More Details. Last Update: July 1,
Preventive Drug List Preventive drugs are used to help avoid disease and maintain health. Some insurance plans have a benefit that allows you to buy preventive drugs at a copay. Check your plan details
More informationLIGHTHOUSE. Stopper Pop-Up and the Effects on. Container Closure of Sterile Vials. Application Note 101 LIGHTHOUSE
Stopper Pop-Up and the Effects on Container Closure of Sterile Vials Stopper Pop-Up and the Effects on Container Closure of Sterile Vials Introduction Container closure integrity plays an important role
More information(List of Covered Drugs)
Superior Select Health Plans H-POS SNP 2019 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN Formulary ID 19550, Version Number 5
More information2019 Ohana Community Care Services (CCS) Comprehensive Preferred Drug List (List of Covered Drugs)
2019 Ohana Community Care Services (CCS) Comprehensive referred Drug List (List of Covered Drugs) Ohana Health lan 00 lease read: This document contains information about the drugs we cover in this plan.
More information92:00. Miscellaneous Therapeutic Agents. 92:00 Miscellaneous Therapeutic Agents
Miscellaneous Therapeutic Agents Miscellaneous Therapeutic Agents ALENDRONATE SODIUM 70 MG ORAL TABLET 00002299712 00002352966 00002381494 00002248730 00002388553 00002385031 00002394871 00002286335 00002284006
More informationMemorial Hermann Advantage HMO Formulary. (List of Covered Drugs)
Memorial Hermann Advantage H 2019 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN HPMS Approved Formulary File Submission ID 19563,
More informationMANUFACTURING PROBLEMS AS OF 11th January 2018
3 MANUFACTURING PROBLEMS AS OF 11th January 2018 If you know of any stock Issues that are not on this list please get in touch at ahope@nhs.net Dumfries and Galloway on the date displayed and may not apply
More information2018 Ohana Community Care Services (CCS) Comprehensive Preferred Drug List (List of Covered Drugs)
2018 Ohana Community Care Services (CCS) Comprehensive referred Drug List (List of Covered Drugs) Ohana Health lan 00 lease read: This document contains information about the drugs we cover in this plan.
More informationGeorgia Medicaid Meeting November 6, 2018
ABBVIE US LLC DUOPA (MISCELL) ANTIPARKINSON'S AGENTS ABBVIE US LLC VENCLEXTA (ORAL) ONCOLOGY, ORAL - HEMATOLOGIC ABBVIE US LLC VENCLEXTA STARTING PACK (ORAL) ONCOLOGY, ORAL - HEMATOLOGIC ACADIA PHARMACE
More informationProvider Partners Health Plan of Ohio (HMO SNP) 2019 Formulary (List of Covered Drugs)
Provider Partners Health Plan of Ohio (H SNP) 2019 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN Formulary ID 19582, Version 5
More informationThe following portfolio data for the Franklin Templeton funds is made available to the public under our Portfolio
The following portfolio data for the Franklin Templeton funds is made available to the public under our Portfolio Holdings Release Policy and is "as of" the date indicated. This portfolio data should not
More informationATRIO Health Plans 2018 SNP Plans Formulary Change Notice
Formulary ID: 18007 ATRIO Special Needs Plan ATRIO Special Needs Plan (Rogue) ATRIO Special Needs Plan (Willamette) ATRIO Health Plans 2018 SNP Plans Formulary Change Notice ATRIO Health Plans may remove
More informationTOP$ Product Review Listing
ABBOTT LABS. ADVICOR (ORAL) LIPOTROPICS, STATINS ABBOTT LABS. ANDROGEL (TRANSDERM.) ANDROGENIC AGENTS ABBOTT LABS. CREON (ORAL) PANCREATIC ENZYMES ABBOTT LABS. GENGRAF (ORAL) IMMUNOSUPPRESSIVES, ORAL ABBOTT
More informationSIGNATURE ADVANTAGE Formulary. (List of Covered Drugs)
SIGNATURE ADVANTAGE 2019 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN Formulary ID 19552, Version Number 5 This formulary was
More informationPreventive Drug List. More Details. Alcohol Dependency Alcohol Dependency acamprosate oral tablet,delayed release (dr/ec) disulfiram oral tablet
Preventive Drug List Preventive drugs are used to help avoid disease and maintain health. Some insurance plans have a benefit that allows you to buy preventive drugs at a copay. Check your plan details
More informationTOP$ May 2014 Product Listing
ABBVIE US LLC ADVICOR (ORAL) LIPOTROPICS, STATINS ABBVIE US LLC ANDROGEL GEL PACKET (TRANSDERM.) ANDROGENIC AGENTS ABBVIE US LLC ANDROGEL GEL PUMP (TRANSDERM) ANDROGENIC AGENTS ABBVIE US LLC CREON (ORAL)
More informationwith the Use of RABS and Isolators Barcelona, Spain October 27, 2015
Aseptic Processing Barrier Technology Trends with the Use of RABS and Isolators Barcelona, Spain October 27, 2015 Jack Lysfjord, Principal Consultant 952 546 2082 jlysfjord@q.com Agenda Background - Diagrams
More informationNew Jersey Department of Human Services State Upper Limit (SUL) List - PROPOSED Effective
New Jersey Department of Human Services State Upper Limit () List - PROPOSED Effective 07-01-2018 New ABACAVIR FATE ORAL TABLET 300 MG ABACAVIR FATE/LAMIVUDINE ORAL TABLET 600-300MG ABACAVIR FATE/LAMIVUDINE/ZIDOVUDINE
More informationSAFETY DATA SHEET. Version: 5.2
Page 1 of 7 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND THE COMPANY/UNDERTAKING Product Identifier Trade Name: Compound Number: Synonyms: Chemical Family: TRUMENBA PF-05212366 TRUMENBA- neisseria meningitidis
More informationPROGRAM 2003 ANNUAL MEETING. American Psychiatric Association. The Promise of Science The Power of Healing AMERICAN PSYCHIATRIC ASSOCIATION
PROGRAM AMERICAN PSYCHIATRIC ASSOCIATION 2003 ANNUAL MEETING American Psychiatric Association 10 I 674 I The Promise of Science The Power of Healing 156th Annual Meeting + May 17-22, 2003 San Francisco,
More informationHeadline Specialty pharmacy drug list
Headline Effective January 1, 2017 BriovaRx, the OptumRx specialty pharmacy, provides comprehensive support services, including access to pharmacists around the clock, for high-cost oral and injectable
More informationAstellas Pharma Europe Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Astellas Pharma Europe Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile Astellas Pharma Europe Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing
More informationPerformance Drug List
January 2018 erformance Drug List lease consider talking to your doctor about rescribing referred medications, which may hel reduce your out-of-ocket costs. This list may hel guide you and your doctor
More information2019 Formulary (List of Covered Drugs)
MEDICARE ADVANTAGE PLANS 2019 Formulary (List of Covered Drugs) Presbyterian Senior Care (HMO) Presbyterian Senior Care (HMO-POS) Presbyterian MediCare PPO Please Read: This document contains information
More informationMemorial Hermann Advantage HMO & PPO Formulary. (List of Covered Drugs)
Memorial Hermann Advantage H & PPO 2017 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN HPMS Approved Formulary File 00017383, Version
More informationHAZARD ANALYSIS AND (HARA) M/S. Almelo Pvt. Ltd. Unit-11 RISK ASSESSMENT STUDIES JULY FOR
Almelo Pvt. Ltd., Unit-II HAZARD ANALYSIS AND RISK ASSESSMENT STUDIES (HARA) FOR M/S. Almelo Pvt. Ltd. Unit-11 Shabashpally (V), Shivampet (M), Medak District, Telangana State. JULY- 2014 Prepared By:
More informationPartnership 2017 Formulary. List of Covered Drugs
Partnership 207 Formulary List of Covered Drugs PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN ID 7379, Version Number 9 This formulary was updated on 5/23/207. For
More informationTOP$ Medicaid February 2009 Meetings
MANUFACTURER BRAND NAME THERAPEUTIC CLASS ABBOTT LABS. ADVICOR (ORAL) LIPOTROPICS, STATINS ABBOTT LABS. CARDIZEM LA (ORAL) CALCIUM CHANNEL BLOCKERS ABBOTT LABS. DEPAKOTE ER (ORAL) ANTICONVULSANTS ABBOTT
More informationLEGEND. Tier 1: Covered Medications
LEGEND : Covered Medications BvD: Part B vs. Part D-This prescription drug may be covered under Medicare Part B or D depending upon the circumstances. HRM: High Risk Medication (PA required for ages 65
More informationThe Onychomycosis Market (2018 Edition) September 2018
The Onychomycosis Market (2018 Edition) September 2018 The US Onychomycosis Market:Coverage Executive Summary and Scope Introduction/Market Overview Global Market Analysis The US Market Analysis Competitive
More information